Image

SABCS 2021: HR-positive, HER2-negative breast ...

oncoXchange |

December 2021

Image

SABCS 2021: Data support T-DXd as second-line ...

oncoXchange |

December 2021

Image

SABCS 2021 - ER-positive breast cancers have ...

oncoXchange |

December 2021

Image

ESMO 2021 - MONALEESA-2: Ribociclib extends O ...

oncoXchange |

October 2021

Image

ESMO 2021 - Immunotherapy, CDK4/6 inhibition ...

oncoXchange |

October 2021

Image

ESMO 2021 - Immunotherapy but not PARP inhibi ...

oncoXchange |

September 2021

Image

ASCO 2021 - Studies confirm utility of MammaP ...

oncoXchange |

June 2021

Image

ASCO 2021 - CDK4/6 inhibition maintains impro ...

oncoXchange |

June 2021

Image

SABCS 2020 - Immunotherapy knowledge in breas ...

oncoXchange |

December 2020

Image

SABCS 2020 - Personalized HER2 strategies ext ...

oncoXchange |

December 2020